Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Compare Fallopian Tube Cells Collected by MAKO 7 With Removed Ovarian / Tubal Tissue to Determine Presence of Malignancy

Prospective, multi-center, non-randomized study to assess the ability of the MAKO 7 device to collect cell samples from the fallopian tube that can be evaluated for the presence or absence of malignancy.
Not Available
N/A
Anderson, Ted
NCT03593681
VICCGYN18131

Provision of Free Varenicline (Chantix) within the Context of a Dedicated Outpatient Tobacco Treatment Clinic (TTC) for Cancer Patients

Not Available
N/A
Tindle, Hilary
VICCTHO18132

11C-Glutamine and 18F-FSPG PET Imaging in Diagnosing Patients with Metastatic Colorectal Cancer

Multiple Cancer Types

The clinical trial studies how well 11C-glutamine and 18F-FSPG positron emission tomography (PET) imaging works in detecting tumors in patients with metastatic colorectal cancer compared to standard imaging methods such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning.
Colon, Rectal
N/A
Manning, Henry
NCT03275974
VICCGI1781

Wren Melanoma Study

Melanoma

Melanoma
N/A
Kauffmann, Rondi
NCT03267381
VICCMEL1783

Chemotherapy Levels in the Blood of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Retinoblastoma (Pediatrics)
N/A
Daniels, Anthony
VICCREACH1792

Chemotherapy Levels in the Eyes of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Retinoblastoma (Pediatrics)
N/A
Daniels, Anthony
VICCREACH17106

Developing Evidence-Based Criteria for Initiating Treatment for Neurofibromatosis Type 1 Associated Optic Pathway Glioma

Multiple Cancer Types

Neuro-Oncology, Pediatrics
N/A
Esbenshade, Adam
VICCPED17108

The Collection of Blood Samples from Patients with NF1 for Research Purposes

Multiple Cancer Types

Neuro-Oncology, Pediatrics
N/A
Esbenshade, Adam
VICCPED17109

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Multiple Cancer Types

This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and / or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Lymphoma, Miscellaneous, Pediatric Solid Tumors
N/A
Borinstein, Scott
NCT03155620
COGAPEC1621SC

Optimization of Cancer Therapy Using Immune Effector Cells

Hematologic

Hematologic
N/A
Oluwole, Olalekan
VICCBMT1834

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: